Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fox, Louis"'
Autor:
Fox L; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Santaolalla A; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Handford J; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Sullivan R; Global Oncology Group, Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Torode J; Global Oncology Group, Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Vanderpuye V; National Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, Accra, Ghana., Pramesh CS; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Mula-Hussain L; Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman., AlWaheidi S; Global Oncology Group, Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom., Makaroff LE; World Bladder Cancer Patient Coalition, Brussels, Belgium., Kaur R; Advanced Breast Cancer Global Alliance, Petaling Jaya, Malaysia., Mackay C; World Ovarian Cancer Coalition, Toronto, ON, Canada., Mukherji D; Naef K Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society and Public Health, King's College London, London, United Kingdom.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2023 Aug; Vol. 9, pp. e2300111.
Autor:
Moss CL; Translational & Oncology Research (TOUR), King's College London, Faculty of Life Sciences & Medicine, London, UK., Guerrero-Urbano T; Guy's Cancer Centre, Guy's & St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, UK., White I; Guy's Cancer Centre, Guy's & St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, UK., Taylor B; Guy's Cancer Centre, Guy's & St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, UK., Kristeleit R; Guy's Cancer Centre, Guy's & St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, UK., Montes A; Guy's Cancer Centre, Guy's & St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, UK., Fox L; Translational & Oncology Research (TOUR), King's College London, Faculty of Life Sciences & Medicine, London, UK., Beyer K; Translational & Oncology Research (TOUR), King's College London, Faculty of Life Sciences & Medicine, London, UK., Sztankay M; Department of Psychiatry, Psychotherapy & Psychosomatics, University Hospital of Psychiatry II, Medical University of Innsbruck, 6020, Innsbruck, Austria., Ratti MM; Clinical & Health Psychology, IRCCS San Raffaele Hospital, Olgettina Street, 60 - 20132, Milan, Italy., Sisca ES; Clinical & Health Psychology, IRCCS San Raffaele Hospital, Olgettina Street, 60 - 20132, Milan, Italy., Derevianko A; Clinical & Health Psychology, IRCCS San Raffaele Hospital, Olgettina Street, 60 - 20132, Milan, Italy., MacLennan S; Academic Urology Unit, Health Services Research Unit, University of Aberdeen, AB24 3FX, Aberdeen, UK., Wood N; Department of Obstetrics & Gynaecology, Lancashire Teaching Hospitals NHS Foundation Trust, PR2 9HT, Lancashire, UK., Wintner LM; Department of Psychiatry, Psychotherapy & Psychosomatics, University Hospital of Psychiatry II, Medical University of Innsbruck, 6020, Innsbruck, Austria., Van Hemelrijck M; Translational & Oncology Research (TOUR), King's College London, Faculty of Life Sciences & Medicine, London, UK.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2023 Mar; Vol. 19 (9), pp. 663-678. Date of Electronic Publication: 2023 May 02.
Autor:
Fox L; King's College London, London, United Kingdom., Sullivan R; King's College London, London, United Kingdom., Mukherji D; Lebanese American University, Beirut, Lebanon., Van Hemelrijck M; King's College London, London, United Kingdom.
Publikováno v:
Frontiers in public health [Front Public Health] 2022 Aug 10; Vol. 10, pp. 988736. Date of Electronic Publication: 2022 Aug 10 (Print Publication: 2022).
Autor:
Fox L; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK., Monroy-Iglesias MJ; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK. Electronic address: maria.j.monroy_iglesias@kcl.ac.uk., Aggarwal A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Haire K; Southeast London Cancer Alliance, London, UK., Purushotham A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Spicer J; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Papa S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Rigg A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Sullivan R; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK.
Publikováno v:
Journal of cancer policy [J Cancer Policy] 2022 Mar; Vol. 31, pp. 100316. Date of Electronic Publication: 2021 Dec 08.
Autor:
Tremble K; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK.; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK., Fox L; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK., Moss C; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK., Russell B; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK., Aljazzaf H; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Higgins F; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Dann B; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Jogia V; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Roberts G; South East London Cancer Alliance, London, SE1 9RT, UK., Rigg A; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK., Dolly S; Guy's & St Thomas' NHS Foundation Trust (GSTT), London, SE1 9RT, UK.; South East London Cancer Alliance, London, SE1 9RT, UK., Van Hemelrijck M; Translational Oncology & Urology Research (TOUR), King's College London, London, SE1 9RT, UK.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Mar; Vol. 18 (10), pp. 1211-1218. Date of Electronic Publication: 2022 Jan 17.
Autor:
Fox L; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Beyer K; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Rammant E; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Morcom E; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Van Hemelrijck M; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Sullivan R; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Vanderpuye V; National Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, Accra, Ghana., Lombe D; Cancer Diseases Hospital & Research Centre, Lahore, Zambia., Tsunoda AT; Hospital Erasto Gaertner, PPGTS / Pontifícia Universidade Católica do Paraná, Curitiba, Brazil., Kutluk T; Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey., Bhoo-Pathy N; Centre for Epidemiology and Evidence-Based Practice, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Pramesh SC; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Yusuf A; Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan., Booth CM; Department of Oncology, Queen's University, Kingston, ON, Canada., Shamieh O; Department of Palliative Medicine, King Hussein Cancer Center, Amman, Jordan., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, Netherlands., Mukherji D; American University of Beirut Medical Center, Beirut, Lebanon.
Publikováno v:
Frontiers in public health [Front Public Health] 2021 Nov 24; Vol. 9, pp. 741223. Date of Electronic Publication: 2021 Nov 24 (Print Publication: 2021).
Autor:
Fox L; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Wylie H; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Haire A; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Green S; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Kibaru J; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
Publikováno v:
Frontiers in public health [Front Public Health] 2021 Oct 29; Vol. 9, pp. 741188. Date of Electronic Publication: 2021 Oct 29 (Print Publication: 2021).
Autor:
Chen M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Raj R; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Fox L; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Moss CL; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., George G; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Karagiannis SN; St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, UK.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Enting D; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Department of Medical Oncology, Guy's and Saint Thomas' NHS Foundation Trust, London, UK., Joseph M; Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK., Peat N; Guy's and St Thomas' NHS Foundation Trust, London, UK., Russell B; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK beth.russell@kcl.ac.uk., Van Hemelrijck M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Oct 08; Vol. 11 (10), pp. e046052. Date of Electronic Publication: 2021 Oct 08.
Autor:
Fox L; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Wylie H; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Cahill F; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Haire A; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Green S; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Kibaru J; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom., Hartley C; Ecancer, Bristol, United Kingdom., Sullivan R; Institute of Cancer Policy, King's College London, United Kingdom., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom.
Publikováno v:
Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2021 Jan-Dec; Vol. 28, pp. 1073274821989315.
Autor:
Fox, Louis
This Phase I scoping review will query the literature with the aim of establishing a 'long list' of quality of life issues in bladder cancer, which will be subjected to a validation process involving patients and clinicians in further Phases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf86d6ce4e6ec69243a410aa4de6baec